Strategy Archives - Medical Patents Broker

May 18, 2026

Practical Reasons to License a medical patent

Practical Strategic Reasons For Manufacturers Licensing A Medical Patent

May 13, 2026

Patent Strategy - The market before the market

The Market Before The Market: Two Bites Of The Apple

May 11, 2026

Surgeon's Patent to Market Story

The 5% Market Share Mystery: The Tale of the Surgeon’s Journey

May 6, 2026

Transitioning Your Patent to Market Exclusivity

Transitioning Pharmaceutical Phase III Data into Market Exclusivity

May 4, 2026

CMS, Medicare, Medicaid and Patent Approval

FDA Approved – But Will CMS Authorize Payment for the Patented Medical Invention?

March 23, 2026

Federal Grant Basics for Medical Devices

Fed Funding: Some of the Basics of Federal Grants for Medical Devices

March 18, 2026

Keeping Your Medical Patent Journey Shipshape

March 16, 2026

Phase 3 death - Tragedy to Transformation

Phase III “Death” – Tragedy or Transformation?

March 11, 2026

Federal Interest Rates and the Intellectual Property Sales Funnel

The Fed and the Funnel: How Interest Rates Affect Your Medical Invention

February 24, 2026

Not Your Grandfather’s Orphan Drug Status

February 23, 2026

Successful Phase I Clinical Trials Can Improve Medical Patent Value

February 17, 2026

The Silent Killer!

February 16, 2026

505-b-2 Advantage “Hybrid” is the Power Move in 2026.webp

The 505(b)(2) Advantage: “Hybrid” is the Power Move in 2026

February 11, 2026

The Surgeon and the 510(k): Why Great Inventions Get Stuck

February 3, 2026

Orchestrating Technology To The Patient℠: The MPB Lifecycle Strategy